CCNJ, the cyclin J, controls the G2/M cell cycle transition and has been implicated as oncogene in different tumors, such as breast and gastric cancer [30,55], bladder cancer [56], and non-small cell lung cancer [57]. Here, CCNJ is linked to urinary bladder carcinoma.